HUMATROPE Side Effects

7017770-9 | Abdominal Distension, Apnoea, Convulsion, Eye Swelling, Lethargy, Malaise, Nasal Congestion, Oedema Peripheral, Oropharyngeal Pain
on Sep 15, 2010 Male patient from UNITED STATES , weighting 68.12 lb, was diagnosed with growth retardation and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, apnoea, convulsion, eye swelling, lethargy, malaise, nasal congestion, oedema peripheral, oropharyngeal pain. Humatrope dosage: 1.1 Mg, Daily (1/d). During the same period patient was treated with TOPAMAX (50 Mg, Daily (1/d)) (View Topamax Review and Topamax Label ).

7005828-X | Autoimmune Disorder, Exposure To Toxic Agent, Incorrect Dose Administered, Nasopharyngitis, Ocular Neoplasm, Weight Increased
Patient was taking Humatrope (View Usage). Patient had the following side effects: autoimmune disorder, exposure to toxic agent, incorrect dose administered, nasopharyngitis, ocular neoplasm, weight increased on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with growth hormone deficiency and. Humatrope dosage: 0.4 Mg, Daily (1/d). During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

7005747-9 | Confusional State, Diarrhoea
Adverse event was reported on Sep 09, 2010 by a Female patient taking Humatrope (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 75 years of age, After Humatrope was administered, patient had the following side effects: confusional state, diarrhoea. Patient was hospitalized.

6977245-X | Cellulitis, Renal Failure Chronic
on Aug 30, 2010 Male patient from UNITED STATES , weighting 375.9 lb, was diagnosed with growth hormone deficiency, type 2 diabetes mellitus and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), renal failure chronic. Humatrope dosage: 2 Mg, Daily (1/d). During the same period patient was treated with BYETTA (5 Ug, 2/d) (View Byetta Review and Byetta Label ), FLOMAX (0.4 Mg, Daily (1/d)) (View Flomax Review and Flomax Label ), TARKA (180 Mg, Daily (1/d)) (View Tarka Review and Tarka Label ), LOVAZA (View Lovaza Review and Lovaza Label ), GLUMETZA (Unk, 2/d) (View Glumetza Review and Glumetza Label ), NEXIUM (40 Mg, Daily (1/d)) (View Nexium Review and Nexium Label ), DIOVAN HCT (1 D/f, Daily (1/d)) (View Diovan Hct Review and Diovan Hct Label ). Patient was hospitalized.


6973223-5 | Arthralgia, Chronic Myeloid Leukaemia, Sciatica, Testicular Pain
on Sep 03, 2010 Male patient from JAPAN , weighting 162.0 lb, was diagnosed with growth hormone deficiency, hypopituitarism, hepatitis c (What is hepatitis c?) and was treated with Humatrope (View Usage). Patient had the following side effects: arthralgia, chronic myeloid leukaemia, sciatica (What is sciatica?), testicular pain. Humatrope dosage: 0.2 Mg, Daily (1/d). During the same period patient was treated with CORTRIL (10 Mg, Each Morning) (View Cortril Review and Cortril Label ), THYRADIN S (100 Ug, Each Morning) (View Thyradin S Review and Thyradin S Label ), ENARMON /00103102/ (125 Mg, Monthly (1/m)) (View Enarmon /00103102/ Review and Enarmon /00103102/ Label ), URSO 250 (200 Mg, 3/d) (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

6972409-3 | Pulmonary Fibrosis
Patient was taking Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?) on Aug 30, 2010 from FRANCE Additional patient health information: Female patient , 15 years of age, . Humatrope dosage: .

6964889-4 | Arthralgia, Chronic Myeloid Leukaemia, Sciatica, Testicular Pain
Adverse event was reported on Aug 27, 2010 by a Male patient taking Humatrope (View Usage) (Dosage: 0.2 Mg, Daily (1/d)) was diagnosed with growth hormone deficiency, hypopituitarism, hepatitis c (What is hepatitis c?) and. Location: JAPAN , weighting 162.0 lb, Patient experienced the following unwanted or unexpected effects: arthralgia, chronic myeloid leukaemia, sciatica (What is sciatica?), testicular pain. During the same period patient was treated with CORTRIL (10 Mg, Each Morning) (View Cortril Review and Cortril Label ), THYRADIN S (100 Ug, Each Morning) (View Thyradin S Review and Thyradin S Label ), ENARMON /00103102/ (125 Mg, Monthly (1/m)) (View Enarmon /00103102/ Review and Enarmon /00103102/ Label ), URSO 250 (200 Mg, 3/d) (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

6940189-3 | Chronic Myeloid Leukaemia, Parkinson's Disease
on Aug 16, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). Patient had the following side effects: chronic myeloid leukaemia, parkinson's disease (What is parkinson's disease?). Humatrope dosage: Unk, Unk. Patient was hospitalized.

6929161-7 | Glomerulonephritis Membranous
on Aug 17, 2010 Male patient from JAPAN , child 9 years of age, was diagnosed with growth hormone deficiency, glomerulonephritis membranous and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: glomerulonephritis membranous. Humatrope dosage: Unk, Unk. During the same period patient was treated with PREDNISOLONE (2.5 Mg, Other) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6914761-0 | Abnormal Behaviour, Adverse Reaction, Arthralgia, Asthma, Autoimmune Thyroiditis, Incorrect Dose Administered, Mental Disorder, Photophobia, Vision Blurred
Patient was taking Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, adverse reaction, arthralgia, asthma (What is asthma?), autoimmune thyroiditis, incorrect dose administered, mental disorder, photophobia, vision blurred on Jul 28, 2010 from UNITED STATES Additional patient health information: Male patient , 17 years of age, was diagnosed with growth retardation and. Humatrope dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

6910148-5 | Adrenal Disorder, Anxiety, Aspiration, Asthma, Chronic Obstructive Pulmonary Disease, Decreased Appetite, Depression, Dyspnoea
Adverse event was reported on Jul 27, 2010 by a Female patient taking Humatrope (View Usage) (Dosage: 0.3 Mg, Daily (1/d)) was diagnosed with hypopituitarism, depression (What is depression?), gastric disorder, thyroid disorder and. Location: UNITED STATES , 64 years of age, weighting 208.0 lb, Patient had the following side effects: adrenal disorder, anxiety (What is anxiety?), aspiration, asthma (What is asthma?), chronic obstructive pulmonary disease, decreased appetite, depression (What is depression?), dyspnoea. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), PRILOSEC (20 Mg, Daily (1/d)) (View Prilosec Review and Prilosec Label ), LEVOXYL (88 Unk, Daily (1/d)) (View Levoxyl Review and Levoxyl Label ), PREMARIN (0.625 Mg, Daily (1/d)) (View Premarin Review and Premarin Label ), CLIMARA (0.1 Mg, Daily (1/d)) (View Climara Review and Climara Label ), MULTI VITAMIN (Unk, Daily (1/d)) (View Multi-vitamin Review and Multi-vitamin Label ), CALCIUM W/VITAMIN D NOS (500 Mg, Daily (1/d)) (View Calcium W/vitamin D Nos Review and Calcium W/vitamin D Nos Label ), FIBERCON (200 Mg, Daily (1/d)) (View Fibercon Review and Fibercon Label ). Patient was hospitalized.

6908025-9 | Chronic Myeloid Leukaemia
on Aug 02, 2010 Male patient from JAPAN , 65 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: chronic myeloid leukaemia. Humatrope dosage: Unk, Unk. Patient was hospitalized.

6882128-X | Atrophy, Diabetes Mellitus, Incorrect Dose Administered, Paralysis, Urinary Bladder Atrophy
on Jul 16, 2010 Female patient from FRANCE , 67 years of age, was diagnosed with postpartum hypopituitarism and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: atrophy, diabetes mellitus, incorrect dose administered, paralysis (What is paralysis?), urinary bladder atrophy. Humatrope dosage: . During the same period patient was treated with HYDROCORTISON (View Hydrocortison Review and Hydrocortison Label ), THYROID PREPARATIONS (View Thyroid Preparations Review and Thyroid Preparations Label ).

6871322-X | Glomerulonephritis Membranous
Patient was taking Humatrope (View Usage). Patient had the following side effects: glomerulonephritis membranous on Jul 14, 2010 from JAPAN Additional patient health information: Male patient , child 9 years of age, was diagnosed with growth hormone deficiency, glomerulonephritis membranous and. Humatrope dosage: Unk, Unk. During the same period patient was treated with PREDNISOLONE (2.5 Mg, Other) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6859781-X | Pneumonia Aspiration, Vomiting
Adverse event was reported on Jul 13, 2010 by a Female patient taking Humatrope (View Usage) (Dosage: 36 Iu, Unk) was diagnosed with growth hormone deficiency and. Location: INDIA , child 3 years of age, After Humatrope was administered, patient had the following side effects: pneumonia aspiration, vomiting.

6835828-1 | Epilepsy, Subarachnoid Haemorrhage
on Jul 07, 2010 Female patient from JAPAN , 28 years of age, was diagnosed with growth hormone deficiency, epilepsy (What is epilepsy?) and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?), subarachnoid haemorrhage. Humatrope dosage: Unk, Unk. During the same period patient was treated with ANTIEPILEPTICS (View Antiepileptics Review and Antiepileptics Label ). Patient was hospitalized.

6821992-7 | Glomerulonephritis Membranous
on Jun 30, 2010 Male patient from JAPAN , child 9 years of age, was diagnosed with growth hormone deficiency, glomerulonephritis membranous and was treated with Humatrope (View Usage). Patient had the following side effects: glomerulonephritis membranous. Humatrope dosage: Unk, Unk. During the same period patient was treated with PREDNISOLONE (2.5 Mg, Other) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6815344-3 | Petit Mal Epilepsy, Tonic Convulsion
Patient was taking Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: petit mal epilepsy, tonic convulsion on Jun 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 107.0 lb, was diagnosed with dwarfism (What is dwarfism?) and. Humatrope dosage: 2.1 Mg, Daily (1/d).

6810205-8 | Pneumonia Aspiration, Vomiting
Adverse event was reported on Jun 24, 2010 by a Female patient taking Humatrope (View Usage) (Dosage: 36 Iu, Unk) was diagnosed with growth hormone deficiency and. Location: INDIA , child 2 years of age, Patient experienced the following unwanted or unexpected effects: pneumonia aspiration, vomiting.

6790725-5 | Colon Cancer, Hepatic Lesion
on Jun 14, 2010 Male patient from ITALY , 50 years of age, was treated with Humatrope (View Usage). Patient had the following side effects: colon cancer, hepatic lesion. Humatrope dosage: . Patient was hospitalized.

6769305-3 | Injury Associated With Device
on Jun 10, 2010 Female patient from JAPAN , child 12 years of age, was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: injury associated with device. Humatrope dosage: .

6759919-9 | Cellulitis, Pyrexia, Renal Disorder
Patient was taking Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), pyrexia, renal disorder on May 27, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with growth hormone deficiency and. Humatrope dosage: 2 Mg, Daily (1/d). During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), FLOMAX (View Flomax Review and Flomax Label ), TARKA (View Tarka Review and Tarka Label ), LOVAZA (View Lovaza Review and Lovaza Label ), GLUMETZA (View Glumetza Review and Glumetza Label ). Patient was hospitalized.

6757634-9 | Cardiac Failure
Adverse event was reported on May 26, 2010 by a Female patient taking Humatrope (View Usage) (Dosage: 1 Mg, Daily (1/d)) was diagnosed with growth hormone deficiency and. Location: JAPAN , 14 years of age, Patient had the following side effects: cardiac failure. Patient was hospitalized.

6739146-1 | Ewing's Sarcoma Recurrent
on May 11, 2010 Male patient from CANADA , weighting 78.48 lb, was diagnosed with growth hormone deficiency, hypothyroidism, prophylaxis and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: ewing's sarcoma recurrent. Humatrope dosage: 1 Mg, Unk. During the same period patient was treated with SYNTHROID (70 Ug, Daily (1/d)) (View Synthroid Review and Synthroid Label ), AMOXIL (View Amoxil Review and Amoxil Label ).

6725998-8 | Psychiatric Decompensation
on May 04, 2010 Male patient from UNITED STATES , child 10 years of age, was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: psychiatric decompensation. Humatrope dosage: . Patient was hospitalized.

6725995-2 | Arrhythmia, Diarrhoea, Vomiting
Patient was taking Humatrope (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), diarrhoea, vomiting on May 12, 2010 from JAPAN Additional patient health information: Male patient , child 1 years of age, . Humatrope dosage: 0.2 Mg, Daily (1/d).

6724258-9 | Injection Site Pain, Product Quality Issue, Product Reconstitution Issue
Adverse event was reported on May 04, 2010 by a Female patient taking Humatrope (View Usage) (Dosage: 0.3 Mg, Daily (1/d)) was diagnosed with growth hormone deficiency and. Location: UNITED STATES , 72 years of age, After Humatrope was administered, patient had the following side effects: injection site pain, product quality issue, product reconstitution issue.

6702584-7 | Back Pain, Device Misuse, Incorrect Dose Administered, Renal Pain, Stent Placement, Weight Increased
on Apr 22, 2010 Female patient from UNITED STATES , 50 years of age, weighting 210.0 lb, was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), device misuse, incorrect dose administered, renal pain, stent placement, weight increased. Humatrope dosage: 0.4 Mg, Daily (1/d).

6700793-4 | Pituitary Tumour Benign
on Apr 22, 2010 Male patient from JAPAN , weighting 138.9 lb, was diagnosed with hypothyroidism, adrenal insufficiency and was treated with Humatrope (View Usage). Patient had the following side effects: pituitary tumour benign. Humatrope dosage: 0.2 Mg, Daily (1/d). During the same period patient was treated with THYRADIN (50 Mg, Daily (1/d)) (View Thyradin Review and Thyradin Label ), CORTRIL (15 Mg, Daily (1/d)) (View Cortril Review and Cortril Label ).

6696521-1 | Abdominal Pain, Adrenal Insufficiency, Cerebrovascular Disorder, Dehydration
Patient was taking Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), adrenal insufficiency, cerebrovascular disorder, dehydration on Apr 22, 2010 from JAPAN Additional patient health information: Female patient , 54 years of age, weighting 169.8 lb, . Humatrope dosage: 0.3 Mg, Daily (1/d). During the same period patient was treated with THYRADIN (View Thyradin Review and Thyradin Label ), CORTRIL (View Cortril Review and Cortril Label ), DORNER (View Dorner Review and Dorner Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TRICOR (View Tricor Review and Tricor Label ), GRAMALIL (View Gramalil Review and Gramalil Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6693180-9 | Bradyphrenia, Cerebrovascular Accident, Mobility Decreased
Adverse event was reported on Apr 13, 2010 by a Male patient taking Humatrope (View Usage) (Dosage: 0.1 Mg, Unk) was diagnosed with brain operation and. Location: UNITED STATES , 85 years of age, Patient experienced the following unwanted or unexpected effects: bradyphrenia, cerebrovascular accident, mobility decreased. During the same period patient was treated with LEVOTHYROXINE (0.125 Mg, Unk) (View Levothyroxine Review and Levothyroxine Label ), OMEPRAZOLE (20 Mg, Unk) (View Omeprazole Review and Omeprazole Label ), HYDROCORTISONE (15 Mg, Unk) (View Hydrocortisone Review and Hydrocortisone Label ), ASPIRIN (375 Mg, Unk) (View Aspirin Review and Aspirin Label ), HYDROCHLOROTHIAZIDE (75 Mg, Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), CALCIUM W/VITAMIN D NOS (600 Mg, 2/d) (View Calcium W/vitamin D Nos Review and Calcium W/vitamin D Nos Label ), ICAPS (4 Mg, 2/d) (View Icaps Review and Icaps Label ).

6686704-9 |
on Apr 15, 2010 Female patient from JAPAN , 54 years of age, was treated with Humatrope (View Usage). . Humatrope dosage: 0.3 Mg, Daily (1/d). During the same period patient was treated with THYRADIN (View Thyradin Review and Thyradin Label ), CORTRIL (View Cortril Review and Cortril Label ), DORNER (View Dorner Review and Dorner Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TRICOR (View Tricor Review and Tricor Label ), GRAMALIL (View Gramalil Review and Gramalil Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6686617-2 | Fluid Retention, Memory Impairment, Pulmonary Embolism, Road Traffic Accident, Weight Increased
on Apr 06, 2010 Female patient from UNITED STATES , weighting 205.0 lb, was diagnosed with brain injury and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: fluid retention, memory impairment, pulmonary embolism (What is pulmonary embolism?), road traffic accident, weight increased. Humatrope dosage: Unk, Each Evening.

6682741-9 | Lung Abscess
Patient was taking Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: lung abscess on Apr 07, 2010 from JAPAN Additional patient health information: Male patient , weighting 63.93 lb, was diagnosed with growth hormone deficiency and. Humatrope dosage: 0.8 Mg, Daily (1/d). Patient was hospitalized.

6663085-8 | Congenital Cystic Kidney Disease, Off Label Use
Adverse event was reported on Mar 29, 2010 by a Male patient taking Humatrope (View Usage) (Dosage: ) . Location: UNITED STATES , 72 years of age, Patient had the following side effects: congenital cystic kidney disease, off label use.

6663074-3 | Lung Abscess, Transmission Of An Infectious Agent Via A Medicinal Product
on Mar 25, 2010 Male patient from JAPAN , weighting 63.93 lb, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: lung abscess, transmission of an infectious agent via a medicinal product. Humatrope dosage: 0.8 Mg, Daily (1/d). Patient was hospitalized.

6663043-3 | Asthenia, Cerebrovascular Accident, Confusional State, Lung Neoplasm Malignant, Memory Impairment, Mobility Decreased, Muscular Weakness, Speech Disorder
on Mar 22, 2010 Female patient from UNITED STATES , 87 years of age, was diagnosed with blood growth hormone and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, cerebrovascular accident, confusional state, lung neoplasm malignant, memory impairment, mobility decreased, muscular weakness, speech disorder. Humatrope dosage: 0.6 Mg, Each Evening. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ), POTASSIUM (View Potassium Review and Potassium Label ), BABY ASPIRIN (View Baby Aspirin Review and Baby Aspirin Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

6658102-5 | Arthritis, Injection Site Irritation, Injection Site Pain, Spinal Column Stenosis
Patient was taking Humatrope (View Usage). Patient had the following side effects: arthritis (What is arthritis?), injection site irritation, injection site pain, spinal column stenosis on Mar 18, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, . Humatrope dosage: 0.3 Mg, Daily (1/d). Patient was hospitalized.

6656179-4 | Tendonitis
Adverse event was reported on Mar 23, 2010 by a Female patient taking Humatrope (View Usage) (Dosage: ) . Location: JAPAN , child 8 years of age, After Humatrope was administered, patient had the following side effects: tendonitis.

6656169-1 | Epilepsy, Subarachnoid Haemorrhage
on Mar 23, 2010 Female patient from JAPAN , 28 years of age, was diagnosed with growth hormone deficiency, epilepsy (What is epilepsy?) and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: epilepsy (What is epilepsy?), subarachnoid haemorrhage. Humatrope dosage: . During the same period patient was treated with ANTIEPILEPTICS (View Antiepileptics Review and Antiepileptics Label ). Patient was hospitalized.

6615916-5 | Kawasaki's Disease
on Mar 01, 2010 Male patient from JAPAN , child 3 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). Patient had the following side effects: kawasaki's disease. Humatrope dosage: 0.3 Mg, Daily (1/d). Patient was hospitalized.

6613664-9 | Surgery
Patient was taking Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: surgery (What is surgery?) on Feb 22, 2010 from JAPAN Additional patient health information: Male patient , child 9 years of age, . Humatrope dosage: .

6605105-2 | Lung Abscess
Adverse event was reported on Feb 18, 2010 by a Male patient taking Humatrope (View Usage) (Dosage: ) . Location: JAPAN , 16 years of age, Patient experienced the following unwanted or unexpected effects: lung abscess. Patient was hospitalized.

6581941-6 | Injury Associated With Device
on Feb 03, 2010 Male patient from JAPAN , child 3 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope (View Usage). Patient had the following side effects: injury associated with device. Humatrope dosage: 0.4 Mg, Daily (1/d). Patient was hospitalized.

6551632-6 | Cerebrovascular Accident, Confusional State, Lung Neoplasm Malignant, Memory Impairment, Mobility Decreased, Muscular Weakness, Speech Disorder
on Jan 18, 2010 Female patient from UNITED STATES , 87 years of age, was diagnosed with blood growth hormone and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: cerebrovascular accident, confusional state, lung neoplasm malignant, memory impairment, mobility decreased, muscular weakness, speech disorder. Humatrope dosage: 0.6 Mg, Each Evening. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ), POTASSIUM (View Potassium Review and Potassium Label ), BABY ASPIRIN (View Baby Aspirin Review and Baby Aspirin Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

6549052-3 | Osteonecrosis
Patient was taking Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?) on Nov 25, 2009 from JAPAN Additional patient health information: Female patient , 14 years of age, was diagnosed with growth hormone deficiency and. Humatrope dosage: .

6549051-1 | Sleep Apnoea Syndrome
Adverse event was reported on Nov 25, 2009 by a Female patient taking Humatrope (View Usage) (Dosage: ) was diagnosed with chondrodystrophy and. Location: JAPAN , child 3 years of age, Patient had the following side effects: sleep apnoea syndrome.

6549050-X | Sleep Apnoea Syndrome
on Nov 25, 2009 Female patient from JAPAN , child 3 years of age, was diagnosed with chondrodystrophy and was treated with Humatrope (View Usage). After Humatrope was administered, patient had the following side effects: sleep apnoea syndrome. Humatrope dosage: .

6549049-3 | Sleep Apnoea Syndrome
on Nov 25, 2009 Female patient from JAPAN , child 3 years of age, was diagnosed with chondrodystrophy and was treated with Humatrope (View Usage). Patient experienced the following unwanted or unexpected effects: sleep apnoea syndrome. Humatrope dosage: .

6547119-7 | Type 1 Diabetes Mellitus
Patient was taking Humatrope (View Usage). Patient had the following side effects: type 1 diabetes mellitus on Jan 11, 2010 from FRANCE Additional patient health information: Female patient , child 11 years of age, weighting 66.14 lb, was diagnosed with growth hormone deficiency and. Humatrope dosage: 0.8 Mg, Daily (1/d) (12mg/3ml) Six Days A Week. Patient was hospitalized.